课题基金 / 基金详情

The COVID-R3ICSAB Study: COVID-19 Wide Impact: Research on the Risk and Resilience In Special Communities of Chinese, South Asian and Black Populations

The COVID-R3ICSAB Study: COVID-19 Wide Impact: Research on the Risk and Resilience In Special Communities of Chinese, South Asian and Black Populations
COVID-R3ICSAB 研究：COVID-19 广泛影响：华人、南亚人和黑人特殊社区的风险和复原力研究
批准号：
460283
负责人：
Liu Peter P
金额：
$36.29万
依托单位：
Ottawa Heart Institute Research Corporation (Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-11-01 至 2023-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=460283&lang=en
关键词：
Covid-19 Health Outcomes Hospitalization Mortality Racial Disparities Social Impacts Underrepresented Populations Visible Minorities

项目摘要

项目成果

Liu Peter P的其他基金

相似基金

相关文献

中文摘要
翻译
2019冠状病毒病对人口中的少数族裔造成了不成比例的影响，死亡率上升，并造成了重大的健康和社会经济后果。 不幸的是，这些信息大部分来自美国和英国的数据，
英文摘要
COVID-19 has disproportionately affected visible minorities in the population, with increased mortality, and major health and socioeconomic consequences with disruptions. Unfortunately most of this information comes from data in the US and UK, as surpris
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Improving Outcomes in Individuals with COVID-19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial
COVID-19 Vaccine-Induced Inflammatory Heart Disease Prevalence Registry and Cohort Study (COVID-VIHPR)
Improving Outcomes in Individuals with COVID-19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial
Developing Novel Therapeutic Targets for Heart Failure
海外基金